Loss of VHL results in a “pseudo-hypoxic” state increasing the expression of HIF-1α and HIF-2α, which results in pathway activations, eventually promoting ccRCC growth and progression [5]. This evidence concerns the gene HIF1A and nonpapillary renal cell carcinoma.